Bill Anderson took charge of Bayer during a turbulent phase. To build on his early momentum, the CEO should focus on structural reform and transparent leadership. Strategic Recommendations Spin-offs: Consider separating the consumer health division to reduce complexity. Debt reduction: Use strategic divestments to reduce liabilities post-Monsanto acquisition. R&D focus: Invest in biotech and digital health to differentiate from competitors. Written by: ScriptDataInsights Labels: business leadership, Bayer, corporate strategy, Bill Anderson, pharma